| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Feb 9, 2021
- Study Compared the Efficacy and Reliability of Medtronic and Masimo Pulse Oximeters with Electrocardiography (ECG) Monitoring for Newborns - Nellcor™ Pulse Oximetry Technology Demonstrated...
-
Nov 24, 2020
- Q2 Revenue of $7.6 Billion Decreased 0.8% Reported and 1.5% Organic - Q2 GAAP Diluted EPS of $0.36; Q2 Non-GAAP Diluted EPS of $1.02 DUBLIN, Nov. 24, 2020 /PRNewswire/ -- Medtronic plc...
-
Nov 16, 2020Results from Three Studies Show Medtronic Cryoablation is Superior to Drug Therapy for First-Line Treatment
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that the primary results of the Medtronic-sponsored STOP AF First clinical trial have been published in the New...
-
Oct 29, 2020New Technologies Address Most Common Challenges During Head and Neck Surgery
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance of the NIM Vital™ nerve monitoring...
-
Sep 23, 2020
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced first enrollments in the ALLEVIATE-HF clinical trial which will evaluate the ability of its Reveal LINQ™...
-
Sep 10, 2020PRODIGY Study Provides First Validated Risk Prediction Tool to Guide Continuous Monitoring for Opioid-Induced Respiratory Depression (OIRD)
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the publication of primary data from PRODIGY (PRediction of Opioid-induced respiratory Depression In patients...
-
Sep 1, 2020New Smartphone Connected Hybrid Closed Loop System Will Be Available to Individuals as Young as 2
DUBLIN – September 1, 2020 – Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval of its...
-
Aug 25, 2020Q1 Revenue of $6.5 Billion Decreased 13% Reported and Approximately 17% Organic
DUBLIN, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced financial results for its first quarter of fiscal year 2021, which ended July 31, 2020. The company reported...
-
Jul 9, 2020
DUBLIN and SAN DIEGO, July 09, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) and Tandem Diabetes Care, Inc. (NASDAQ:TNDM) today announced that they have entered into a non-exclusive patent...
-
Jul 7, 2020Next Generation ICM Offers Remote Programming with Improved Longevity and Enhanced Accuracy
DUBLIN, July 07, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) clearance and...